(Q31035619)

28 June 2017

title

A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog. (English)

1 reference

28 June 2017

1 reference

9

Johan Gabrielsson

1 reference

28 June 2017

Anna Ollerstam

1

1 reference

28 June 2017

Anna H Persson

2

1 reference

28 June 2017

Sandra A G Visser

3

1 reference

28 June 2017

J Magnus Fredriksson

4

1 reference

28 June 2017

Tomas Forsberg

5

1 reference

28 June 2017

Lars B Nilsson

6

1 reference

28 June 2017

Göran Eklund

7

1 reference

28 June 2017

Stig Johan Wiklund

8

1 reference

28 June 2017

Göran Duker

10

1 reference

28 June 2017

Ahmad Al-Saffar

11

1 reference

28 June 2017

publication date

3 March 2006

1 reference

Journal of Pharmacological and Toxicological Methods

28 June 2017

published in

1 reference

28 June 2017

volume

55

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

35-48

1 reference

Is QT interval prolongation a strong or weak predictor for cardiac death?

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Drugs effects on ventricular repolarization: a critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Individual patterns of QT/RR relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Physiological mechanisms influencing cardiac repolarization and QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Relationship between QT interval and heart rate in Alderley Park beagles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Inhibition of L-type Ca2+ channel current in rat ventricular myocytes by terfenadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Terfenadine block of sodium current in canine atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Influence of atenolol on the kinetics of RT interval rate adaptation in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

An improved method to correct the QT interval of the electrocardiogram for changes in heart rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.02.009

10.1016/J.VASCN.2006.02.009

7 January 2021

Identifiers

DOI

1 reference

28 June 2017

1 reference